Aetna Beats Analyst Estimates on EPS
Aetna (NYS: AET) reported earnings on Feb. 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Aetna met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue was unchanged and GAAP earnings per share improved significantly.
Margins grew across the board.
Aetna booked revenue of $8.54 billion. The 12 analysts polled by S&P Capital IQ expected sales of $8.51 billion. Sales were 0.4% higher than the prior-year quarter's $8.51 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.
Non-GAAP EPS came in at $0.97. The 20 earnings estimates compiled by S&P Capital IQ predicted $0.96 per share on the same basis. GAAP EPS of $1.03 for Q4 were 91% higher than the prior-year quarter's $0.54 per share.
Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.
For the quarter, gross margin was 29.6%, 270 basis points better than the prior-year quarter. Operating margin was 7.8%, 310 basis points better than the prior-year quarter. Net margin was 4.3%, 180 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $8.74 billion. On the bottom line, the average EPS estimate is $1.37.
Next year's average estimate for revenue is $35.44 billion. The average EPS estimate is $5.09.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 561 members out of 607 rating the stock outperform, and 46 members rating it underperform. Among 215 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 210 give Aetna a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Aetna is outperform, with an average price target of $50.50.
If you're interested in health-care stocks like Aetna, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add Aetna to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.